EXPLORING MELD (MODEL FOR END STAGE LIVER DISEASE) FURTHER

被引：0
|
作者：
Habib, S. [1 ]
Karmegam, S. [2 ]
Desai, C. [3 ]
Gruessner, A. [3 ]
Gruessner, R. [3 ]
Boyer, T. [2 ]
Khan, K. [3 ]
机构：
[1] Univ Arizona, Coll Med, Dept Abdominal Transplant, Tucson, AZ USA
[2] Univ Arizona, Coll Med, Div Internal Med, Tucson, AZ USA
[3] Univ Arizona, Coll Med, Div Transplantat, Tucson, AZ USA
来源：
JOURNAL OF HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
10.1016/S0168-8278(12)60209-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
196
引用
收藏
页码：S84 / S84
页数：1
相关论文
共 50 条
  • [11] Model for end-stage liver disease (MELD) exception for severe pruritus
    Washburn, W. Kenneth
    Gish, Robert G.
    LIVER TRANSPLANTATION, 2006, 12 (12) : S119 - S119
  • [12] Model for end-stage liver disease (MELD) exception for bacterial cholangitis
    Gores, Gregory J.
    Gish, Robert G.
    Shrestha, Roshan
    Wiesner, Russell H.
    LIVER TRANSPLANTATION, 2006, 12 (12) : S91 - S92
  • [13] Model for End-Stage Liver Disease (MELD) and allocation of donor livers
    Wiesner, R
    Edwards, E
    Freeman, R
    Harper, A
    Kim, R
    Kamath, P
    Kremers, W
    Lake, J
    Howard, T
    Merion, RM
    Wolfe, RA
    Krom, R
    GASTROENTEROLOGY, 2003, 124 (01) : 91 - 96
  • [14] Graphical display of Model for End-stage Liver Disease (MELD) score
    Chiarla, Carlo
    Giovannini, Ivo
    Ardito, Francesco
    Vellone, Maria
    Giuliante, Felice
    LIVER INTERNATIONAL, 2012, 32 (08) : 1322 - 1323
  • [15] Model for end-stage liver disease (MELD) exception for hepatic encephalopathy
    Ham, John
    Gish, Robert G.
    Mullen, Kevin
    LIVER TRANSPLANTATION, 2006, 12 (12) : S102 - S104
  • [16] THE IMPACT OF LISTING MODEL FOR END-STAGE LIVER DISEASE (MELD) SCORE ON LIVER TRANSPLANTATION
    Fox, Alyson N.
    Reddy, Rajender
    Guttenberg, Katie B.
    Forde, Kimberly A.
    Ellenberg, Susan
    Lewis, James D.
    HEPATOLOGY, 2010, 52 (04) : 664A - 664A
  • [17] Impact of the Model for End-Stage Liver Disease (MELD) Score on Liver Transplantation in Greece
    Karapanagiotou, A.
    Kydona, C.
    Dimitriadis, C.
    Papadopoulos, S.
    Theodoridou, T.
    Tholioti, T.
    Fouzas, G.
    Imvrios, G.
    Gritsi-Gerogianni, N.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (09) : 3212 - 3215
  • [18] Model for end-stage liver disease (MELD) exception for unusual metabolic liver diseases
    McDiarmid, Sue
    Gish, Robert G.
    Horslen, Simon
    Mazariegos, George V.
    LIVER TRANSPLANTATION, 2006, 12 (12) : S124 - S127
  • [19] Could tenofovir modify the model end-stage liver disease (MELD) score in patients with end-stage liver disease eligible for liver transplantation?
    Bruno, Raffaele
    Sacchi, Paolo
    Filice, Gaetano
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (01) : 123 - 123
  • [20] Liver Transplantation Outcomes in Recipients with High Model for End-Stage Liver Disease (MELD) Scores: The Relevance of MELD Scores
    Wronka, Karolina Maria
    Grat, Michal
    Stypulkowski, Jan
    Bik, Emil
    Krasnodebski, Maciej
    Masior, Lukasz
    Grat, Karolina
    Patkowski, Waldemar
    Krawczyk, Marek
    ANNALS OF TRANSPLANTATION, 2017, 22 : 251 - 256
12345